ATARA Biotherapeutics (ATRA) Tops Q1 EPS by 350c

ATARA Biotherapeutics (NASDAQ: ATRA) reported Q1 EPS of $3.50. Revenue for the quarter came in at $98.15 million.

For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• WiMi proposes quantum convolutional neural network for data tasks
• Citadel has shed over 80% of aggregate risk from Situational Awareness portfolio - CNBC